Systemic comorbidities associated with rosacea: a multicentric retrospective observational study

Simple item page
dc.contributor.authorAksoy B.
dc.contributor.authorEkiz Ö.
dc.contributor.authorUnal E.
dc.contributor.authorOzaydin Yavuz G.
dc.contributor.authorGonul M.
dc.contributor.authorKulcu Cakmak S.
dc.contributor.authorPolat M.
dc.contributor.authorBilgic Ö.
dc.contributor.authorBaykal Selcuk L.
dc.contributor.authorUnal I.
dc.contributor.authorKaradag A.S.
dc.contributor.authorKilic A.
dc.contributor.authorBalta I.
dc.contributor.authorKutlu Ö.
dc.contributor.authorUzuncakmak T.K.
dc.contributor.authorGunduz K.
dc.date.accessioned2024-07-22T08:08:29Z
dc.date.available2024-07-22T08:08:29Z
dc.date.issued2019
dc.description.abstractBackground: Once considered a disorder limited to the skin, rosacea is now known to be associated with systemic disorders. The aim of this study was to determine what systemic comorbidities accompany rosacea and to determine the relationship between the type, severity, and duration of rosacea, and the presence of and type of systemic comorbidities. Methods: This retrospective multicenter study was conducted by the Turkish Society of Dermatology Acne Study Group. Thirteen dermatology clinics throughout Turkey participated in the study. A structured physician-administered questionnaire was used to collect patient demographics, clinical findings, and lifestyle data. The principal rosacea subtype, physician global assessment of severity, and duration of rosacea were recorded. Physicians recorded each participant's medical history, including current and past comorbidities, duration of any such comorbidity, and the use of medications to treat any comorbidities. Results: The study included 1,195 rosacea patients and 621 controls without rosacea aged 18–85 years. As compared to the controls, more of the rosacea patients had respiratory tract, gastrointestinal system, and metabolic and hepatobiliary system disorders in a rosacea's severity- and duration-dependent manner. Conclusion: Clinicians must be aware of the potential for systemic comorbidities in rosacea patients, which becomes more likely as disease duration and severity increase. © 2018 The International Society of Dermatology
dc.identifier.DOI-ID10.1111/ijd.14353
dc.identifier.issn00119059
dc.identifier.urihttp://akademikarsiv.cbu.edu.tr:4000/handle/123456789/14402
dc.language.isoEnglish
dc.publisherBlackwell Publishing Ltd
dc.subjectAdolescent
dc.subjectAdult
dc.subjectAged
dc.subjectAged, 80 and over
dc.subjectCase-Control Studies
dc.subjectComorbidity
dc.subjectFemale
dc.subjectHumans
dc.subjectMale
dc.subjectMiddle Aged
dc.subjectRetrospective Studies
dc.subjectRosacea
dc.subjectSeverity of Illness Index
dc.subjectTime Factors
dc.subjectTurkey
dc.subjectYoung Adult
dc.subjectadult
dc.subjectaged
dc.subjectArticle
dc.subjectcase control study
dc.subjectclinical feature
dc.subjectcomorbidity
dc.subjectcontrolled study
dc.subjectdemography
dc.subjectdisease association
dc.subjectdisease duration
dc.subjectdisease severity
dc.subjectdrug use
dc.subjectfemale
dc.subjectgastrointestinal disease
dc.subjecthepatobiliary disease
dc.subjecthuman
dc.subjectlifestyle
dc.subjectmajor clinical study
dc.subjectmale
dc.subjectmetabolic disorder
dc.subjectobservational study
dc.subjectrespiratory tract disease
dc.subjectretrospective study
dc.subjectrosacea
dc.subjectstructured questionnaire
dc.subjectTurkey (republic)
dc.subjectadolescent
dc.subjectclinical trial
dc.subjectcomorbidity
dc.subjectmiddle aged
dc.subjectmulticenter study
dc.subjectrosacea
dc.subjectseverity of illness index
dc.subjecttime factor
dc.subjectturkey (bird)
dc.subjectvery elderly
dc.subjectyoung adult
dc.titleSystemic comorbidities associated with rosacea: a multicentric retrospective observational study
dc.typeArticle

Files

Collections

Scopus Koleksiyonu